» Authors » Viji Pulikkel Chandran

Viji Pulikkel Chandran

Explore the profile of Viji Pulikkel Chandran including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 94
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Rashid M, Nair S, Poojari P, Belle V, Kunhikatta V, Vaz D, et al.
Heliyon . 2025 Feb; 11(3):e42146. PMID: 39916845
Objective: Diverse inflammatory pathology is involved in acute respiratory distress syndrome (ARDS). This study aimed to assess the role of complement component fragment 5a (C5a) receptor 2 (C5aR2) in prognosis...
2.
Rashid M, Poojari P, Chandran V, Shetty R, Kaur H, Nair S, et al.
Curr Rev Clin Exp Pharmacol . 2024 May; 20(1):38-48. PMID: 38797902
Objective: There is a lack of evidence on the effectiveness of antidotes in the management of organophosphate and carbamate (OPC) poisoning. We aimed to review the efficacy and safety of...
3.
Reghunath S, Rashid M, Chandran V, Thunga G, Shivashankar K, Acharya L
Diabetes Metab Syndr . 2023 Jun; 17(7):102790. PMID: 37329838
Background And Aim: Adverse drug reactions are one of the contributors to increased hospital admission and length of hospital stay. Among the various antidiabetic agents prescribed, dipeptidyl peptidase-4 (DPP-4) inhibitors...
4.
Kaur H, Chandran V, Rashid M, Kunhikatta V, Poojari P, Bakkannavar S, et al.
J Forensic Leg Med . 2023 Jun; 97:102548. PMID: 37327568
The Acute Physiology and Chronic Health Evaluation II (APACHE II) scoring system is utilised as a prognostic method in paraquat poisoning; however, current evidence shows ambiguity. Although some studies have...
5.
Rashid M, Ramakrishnan M, Muthu D, Chandran V, Thunga G, Kunhikatta V, et al.
Clin Epidemiol Glob Health . 2023 Jun; 13:100972. PMID: 37309426
Purpose: The clinical profile and factors affecting outcomes in acute respiratory distress syndrome (ARDS) from adequately sample-sized Indian studies are still lacking. We aimed to investigate the clinical profile, treatment...
6.
Ramakrishnan M, Poojari P, Rashid M, Nair S, Chandran V, Thunga G
Clin Epidemiol Glob Health . 2023 Feb; 20:101243. PMID: 36743947
Problem Considered: Coronavirus disease(COVID-19) outbroke towards the end of December 2019 in China, soon it started spreading rapidly to various countries leading to an outburst of pandemic. Due to the...
7.
Suhita R, Begum I, Rashid M, Chandran V, Shastri S, Kantamneni R, et al.
East Mediterr Health J . 2022 Dec; 28(12):909-916. PMID: 36573572
Background: The World Health Organization estimates that there are approximately 5.4 million snakebites and 1.8-2.7 million cases of envenomation, with 81 410-137 880 deaths each year worldwide. Aims: To estimate...
8.
Shastri S, Kantamneni R, Rashid M, Chandran V, Suhita R, Begum I, et al.
Med Pharm Rep . 2022 Dec; 95(4):357-369. PMID: 36506599
Background And Objective: Proton Pump Inhibitors (PPIs) reduce gastric acid production and they are indicated for myriad gastrointestinal conditions. Prolonged use of PPI has been linked to the risk of...
9.
Rashid M, Rajan A, Chhabra M, Kashyap A, Chandran V, Venkataraman R, et al.
Seizure . 2022 Oct; 102:36-50. PMID: 36183454
Purpose: Antiepileptic drugs (AEDs) are extensively used to manage epilepsy and other comorbidities associated with seizures. Human Leukocyte Antigen (HLA) has a strong association with AED-induced severe cutaneous adverse drug...
10.
Rashid M, Ramakrishnan M, Chandran V, Nandish S, Nair S, Shanbhag V, et al.
Artif Intell Med . 2022 Sep; 131:102361. PMID: 36100348
Background And Objective: Acute respiratory distress syndrome (ARDS) is a life-threatening pulmonary disease with a high clinical and cost burden across the globe. Artificial intelligence (AI), an emerging area, has...